source
- STAT+: Medicare’s miss on Alzheimer’s drug spendingFar fewer seniors than expected are taking costly Alzheimer's drugs.STAT · 2mo ago↗ source
- No FDA permission, no problem: New flavored vape policy worries expertsA new FDA policy will let some flavored vapes stay on the market without authorization.STAT · 2mo ago↗ source
- STAT+: Astellas treatment offers new hope to a devastated rare disease communityAlzheimer's drug rollout letdown, a China-based heart drug startup, and more biotech news from The ReadoutSTAT · 2mo ago↗ source